6URF image
Entry Detail
PDB ID:
6URF
Keywords:
Title:
Malic enzyme from Mycobacterium tuberculosis
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2019-10-23
Release Date:
2020-10-28
Method Details:
Experimental Method:
Resolution:
3.60 Å
R-Value Free:
0.32
R-Value Work:
0.30
R-Value Observed:
0.30
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:NAD-dependent malic enzyme
Chain IDs:A, B, C, D
Chain Length:570
Number of Molecules:4
Biological Source:Mycobacterium tuberculosis
Ligand Molecules
Primary Citation
Structural and Molecular Dynamics of Mycobacterium tuberculosis Malic Enzyme, a Potential Anti-TB Drug Target.
Acs Infect Dis. 7 174 188 (2021)
PMID: 33356117 DOI: 10.1021/acsinfecdis.0c00735

Abstact

Tuberculosis (TB) is the most lethal bacterial infectious disease worldwide. It is notoriously difficult to treat, requiring a cocktail of antibiotics administered over many months. The dense, waxy outer membrane of the TB-causing agent, Mycobacterium tuberculosis (Mtb), acts as a formidable barrier against uptake of antibiotics. Subsequently, enzymes involved in maintaining the integrity of the Mtb cell wall are promising drug targets. Recently, we demonstrated that Mtb lacking malic enzyme (MEZ) has altered cell wall lipid composition and attenuated uptake by macrophages. These results suggest that MEZ contributes to lipid biosynthesis by providing reductants in the form of NAD(P)H. Here, we present the X-ray crystal structure of MEZ to 3.6 Å. We use biochemical assays to demonstrate MEZ is dimeric in solution and to evaluate the effects of pH and allosteric regulators on its kinetics and thermal stability. To assess the interactions between MEZ and its substrate malate and cofactors, Mn2+ and NAD(P)+, we ran a series of molecular dynamics (MD) simulations. First, the MD analysis corroborates our empirical observations that MEZ is unusually flexible, which persists even with the addition of substrate and cofactors. Second, the MD simulations reveal that dimeric MEZ subunits alternate between open and closed states, and that MEZ can stably bind its NAD(P)+ cofactor in multiple conformations, including an inactive, compact NAD+ form. Together the structure of MEZ and insights from its dynamics can be harnessed to inform the design of MEZ inhibitors that target Mtb and not human malic enzyme homologues.

Legend

Protein

Chemical

Disease

Primary Citation of related structures